Literature DB >> 22972453

Advances in the investigation of obstructive jaundice.

J Addley1, R M Mitchell.   

Abstract

The causes of obstructive jaundice are varied, and timely, accurate methods of investigation are essential to avoid the development of complications. Imaging, invasive or non-invasive, should be carefully selected depending on the suspected underlying pathology in order to determine the degree and level of obstruction along with tissue acquisition and staging where relevant. Several imaging techniques will also allow subsequent therapeutic interventions to be carried out. This article reviews advances in the investigation of obstructive jaundice, highlighting recent developments, many of which at present remain restricted to large centres of expertise, but are likely to become more widespread in use as research progresses and local experience continues to improve.

Entities:  

Mesh:

Year:  2012        PMID: 22972453     DOI: 10.1007/s11894-012-0285-1

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  93 in total

Review 1.  CT and magnetic resonance imaging in pancreatic and biliary tract malignancies.

Authors:  Koenraad J Mortele; Hoon Ji; Pablo R Ros
Journal:  Gastrointest Endosc       Date:  2002-12       Impact factor: 9.427

2.  EUS 2008 Working Group document: evaluation of EUS-guided choledochoduodenostomy (with video).

Authors:  Takao Itoi; Kenji Yamao
Journal:  Gastrointest Endosc       Date:  2009-02       Impact factor: 9.427

3.  ERCP, biliary crystal analysis, and sphincter of Oddi manometry in idiopathic recurrent pancreatitis.

Authors:  Madhukar Kaw; George J Brodmerkel
Journal:  Gastrointest Endosc       Date:  2002-02       Impact factor: 9.427

4.  Relative merits of ultrasonography, computed tomography and cholangiography in patients of surgical obstructive jaundice.

Authors:  M Kumar; R Prashad; A Kumar; R Sharma; S K Acharya; T K Chattopadhyay
Journal:  Hepatogastroenterology       Date:  1998 Nov-Dec

5.  Gallstone pancreatitis: a prospective study on the incidence of cholangitis and clinical predictors of retained common bile duct stones.

Authors:  L Chang; S K Lo; B E Stabile; R J Lewis; C de Virgilio
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

6.  The insensitivity of sonography in the detection of choledocholithiasis.

Authors:  D M Einstein; S A Lapin; P W Ralls; J M Halls
Journal:  AJR Am J Roentgenol       Date:  1984-04       Impact factor: 3.959

7.  Value of sonography in obstructive jaundice. Limitations of bile duct caliber as an index of obstruction.

Authors:  O M Pedersen; K Nordgård; S Kvinnsland
Journal:  Scand J Gastroenterol       Date:  1987-10       Impact factor: 2.423

8.  Bile duct obstruction: radiologic evaluation of level, cause, and tumor resectability.

Authors:  R N Gibson; E Yeung; J N Thompson; D H Carr; A P Hemingway; H A Bradpiece; I S Benjamin; L H Blumgart; D J Allison
Journal:  Radiology       Date:  1986-07       Impact factor: 11.105

9.  Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.

Authors:  Wolfgang Schima; Reinhold Függer; Ewald Schober; Claudia Oettl; Peter Wamser; Florian Grabenwöger; J Mark Ryan; Gottfried Novacek
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

10.  Role of duodenal bile crystal analysis in the investigation of 'idiopathic' pancreatitis.

Authors:  J P Neoptolemos; B R Davidson; A F Winder; D Vallance
Journal:  Br J Surg       Date:  1988-05       Impact factor: 6.939

View more
  3 in total

1.  An ultrasound-based approach to jaundice from diagnosis to treatment.

Authors:  Gianpaolo Vidili; Marco Arru; Beatrice Solinas; Davide Turilli
Journal:  Intern Emerg Med       Date:  2022-10-22       Impact factor: 5.472

2.  Simvastatin augments activation of liver regeneration through attenuating transforming growth factor-β1 induced-apoptosis in obstructive jaundice rats.

Authors:  Dazheng Fang; Ying He; Zhou Luan
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

3.  Inhibition of heat shock protein 90 alleviates cholestatic liver injury by decreasing IL-1β and IL-18 expression.

Authors:  Chenhao Tong; Jiandong Li; Weiguo Lin; Wenda Cen; Weiguang Zhang; Zhiyang Zhu; Baochun Lu; Jianhua Yu
Journal:  Exp Ther Med       Date:  2021-01-21       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.